ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

NCI To Recomplete CIDAC Contracts

September 23, 1977

PROPOC Study Analyses Six Cancer DRGs

January 17, 1986

NCI Clinical Research Too Similar To Work By Extramural Community, Report Finds

July 21, 1995

NCI Programs: Director Challenges Scientists To Develop Molecular “Fingerprints” Of Tumors

December 4, 1998

“Dollars For Docs” Database Of Pharma Payments Posted By News Organization

October 22, 2010

Rapid Non-Invasive Imaging Of Biochemical Composition In Breast Tumor Margins

April 24, 2009